COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protectionArticle Published on 2022-10-152022-11-15 Journal: Journal of Biomedical Science [Category] [DOI] 10.1186/s12929-022-00853-8 PMC 바로가기
Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance studyArticle Published on 2022-10-032022-11-15 Journal: Revista do Instituto de Medicina Tropical de São [Category] [DOI] 10.1590/S1678-9946202264056 PMC 바로가기
Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses증례 보고: 백신 접종 반응이 없는 다발성 경화증 환자에서 SARS-CoV-2 감염의 변종 특이적 노출 전 예방Case Reports Published on 2022-07-252022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.897748 PMC 바로가기 [Article Type] Case Reports
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trialSARS-CoV-2 및 S-Trimer(SCB-2019) COVID-19 백신에 대한 이전 노출이 재감염 위험에 미치는 영향: 무작위 배정, 이중 맹검, 위약 대조, 2상 및 3상 시험Clinical Trial Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(22)00144-X PMC 바로가기 [Article Type] Clinical Trial
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial이종 ChAdOx1/BNT162b2 예방 접종은 동종 ChAdOx1 예방 접종보다 더 강한 면역 반응을 유도합니다. 실용적인, 다기관, 3군, 부분 무작위 HEVACC 시험Randomized Controlled Trial Published on 2022-06-012022-09-11 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.104073 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection Research Published on 2022-04-272022-10-05 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-29909-x [Article Type] Research
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trialRandomized Controlled Trial Published on 2022-04-012022-10-04 Journal: Clinical microbiology and infection : the official [Category] [DOI] 10.1016/j.cmi.2021.12.026 PMC 바로가기 [Article Type] Randomized Controlled Trial
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial합성 다항원 변형 백시니아 바이러스 앙카라 기반 COVID-19 백신(COH04S1)의 안전성 및 면역원성: 공개 및 무작위 배정, 1상 시험Clinical Trial Published on 2022-04-012022-09-11 Journal: The Lancet. Microbe [Category] [DOI] 10.1016/S2666-5247(22)00027-1 PMC 바로가기 [Article Type] Clinical Trial
The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World DataArticle Published on 2022-02-172022-10-28 Journal: Vaccines [Category] [DOI] 10.3390/vaccines10020320 PMC 바로가기 [Article Type] Article
Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national dataEpidemiology Published on 2022-02-142022-10-28 Journal: BMJ Open [Category] [DOI] 10.1136/bmjopen-2021-050062 PMC 바로가기 [Article Type] Epidemiology